-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
November 01, 2010 - asymptomatic, monitoring these CKD patients for
worsening function or damage is only possible with laboratory testing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-assessment-research-updates_research.pdf
September 15, 2008 - Updating Current Effectiveness Reviews
Assessment of the Need to Update Comparative Effectiveness
Reviews:
Report of an Initial Rapid Program Assessment (2005-2009)
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
January 31, 2013 - Similarly, an ABI
>1.30 is abnormal and requires further testing. … If an ABI measurement at rest or at exercise is suggestive
of PAD, further noninvasive testing is usually … performed to characterize the anatomic location
and severity of the disease; such testing includes … Continuous variable outcomes will be summarized by mean and standard
deviation; significance testing … Categorical variable outcomes will be
summarized by proportions; significance testing will be performed
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/study-design-framework_research.pdf
March 01, 2012 - following categories of
studies and their descriptions are derived from the AHRQ report ―Developing and Testing … duration: Although expensive to create and maintain, additional
repositories will allow more biomarker testing … Developing
and Testing a Tool for the Classification of
Study Designs in Systematic Reviews of … The study is hypothesis generating rather than testing.
Generally, one is unable to infer cause.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-treatments-chronic-pain-protocol.pdf
December 19, 2018 - opioid therapy, what is the
accuracy of instruments and tests (including metabolic and/or genetic testing … effectiveness of use of risk prediction
instruments and tests (including metabolic and/or genetic testing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-bias-individual-studies_methods.pdf
March 01, 2012 - out recommended approaches to assessment of risk of bias in
five steps: protocol development, pilot testing … assessment of risk of bias forms
and instructions in response to problems arising in training and pilot testing … Developing and testing a tool for the
classification of study designs in systematic
reviews of interventions … No formal reliability testing has been
undertaken and the tool is interpreted as a summed score across … Developing and testing a tool for the
classification of study designs in systematic
reviews of interventions
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-stenting_research-protocol.pdf
August 19, 2011 - Question 5: What factors (e.g., patient/physician characteristics, availability of prior
noninvasive testing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-imaging_disposition-comments.pdf
October 01, 2014 - Disposition of Comments Report for Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer
Technical Brief Disposition of Comments Report
Research Review Title: Imaging Techniques for Treatment Evaluation for Metastatic Breast
Cancer
Draft review available for public comment from Februa…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_executive.pdf
April 01, 2013 - for these
applications: (1) evaluating interventions proven effective
in non-SMI populations, (2) testing … We found no studies
testing a number of important interventions (e.g., orlistat,
statins) known to … Metabolic testing rates
in 3 state Medicaid programs after FDA warnings and ADA/APA
recommendations … Small area variation
and geographic and patient-specific determinants of metabolic
testing in antipsychotic
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-provider-adherence_research-protocol.pdf
March 02, 2012 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: March 2, 2012
1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Interventions to Modify Healthcare Provider Adherence to Asthma
Guidelines
Amendment Date(s) …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-biopsy-update_clinician.pdf
May 01, 2016 - Core-Needle Biopsy for Breast Abnormalities
Core-Needle Biopsy for Breast Abnormalities
Clinical Issue
About one in eight women in the United States will develop
invasive breast cancer during her lifetime. Approximately
290,000 new cases of breast cancer are diagnosed each year
in the United States, and more than…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment_research-protocol.pdf
September 13, 2012 - dressings are classified as devices
and not drugs, the FDA does not require rigorous clinical trial testing … Ulcer area and depth
• Duration of ulcer (short vs. long term)
• Comorbid conditions
• Venous duplex testing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/grading.ppt
January 01, 2010 - In the absence of statistical testing or measurement of heterogeneity, EPC reviewers can assess consistency
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-3.pdf
February 01, 2018 - Quantitative Synthesis Chapter 3. Choice of Statistical Model for Combining Studies
Quantitative Synthesis
Chapter 3. Choice of Statistical Model for Combining Studies
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Systematic Reviews Methods Guide
www.ahrq.gov
Presenter…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
May 01, 2006 - Layout 1
Background
Anemia (deficiency of red blood cells)
occurs in 13-78 percent of patients
undergoing treatment for solid tumors and
30-40 percent of patients treated for
lymphoma. Tumor type, treatment
regimen, and history of prior cancer
therapy influence the risk and severity of
anemia. For example, among pa…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-treatment-adherence_disposition-comments.pdf
December 20, 2012 - some cohort studies which described
interesting features of interventions that may warrant further
testing … It is possible that trials testing the
efficacy of pegIFN-alpha were
published before2001. … Regarding the search cut-off date, it is
possible that trials testing the efficacy
of pegIFN-alpha
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/single-group-studies_white-paper.pdf
January 01, 2013 - Association of transcutaneous bilirubin
testing in hospital with decreased readmission
rate for hyperbilirubinemia … trials: the use of historical data for
determining "go/no go" decision for definitive
phase III testing
-
effectivehealthcare.ahrq.gov/sites/default/files/grading.ppt
January 01, 2013 - In the absence of statistical testing or measurement of heterogeneity, EPC reviewers can assess consistency
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-social-isolation-older-adults-final.pdf
February 01, 2019 - completed training before assessing risk of
bias to improve inter-rater reliability, including pilot testing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/meditation_research-protocol.pdf
October 17, 2012 - Source: www.effectivehealthcare.ahrq.gov
Published Online: October 17, 2012
Evidence-based Practice Center Systematic Review Protocol
Project Title: Meditation Programs for Stress and Well-Being
Amendment Date(s) if applicable: October 10, 2012
(Amendments Details–see Section VII)
I. Background
Me…